The results indicated that D-EDA significantly increased the expression of CD4, CD8a, and B220, suggesting enhanced immune cell activation and improved immune function in erythroleukemia mice (Figure 7A,B,E–G). This evidence concerns the gene PTPRC and erythroleukemia.